Cargando…

Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer

BACKGROUND: Patient-reported outcomes have been associated with survival in numerous studies across cancer types, including breast cancer. However, the Brief Pain Inventory-Short Form (BPI-SF) and the Rotterdam Symptom Checklist (RSCL) have rarely been investigated in this regard in breast cancer. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smyth, Emily Nash, Shen, Wei, Bowman, Lee, Peterson, Patrick, John, William, Melemed, Allen, Liepa, Astra M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807577/ https://www.ncbi.nlm.nih.gov/pubmed/27016084 http://dx.doi.org/10.1186/s12955-016-0449-z

Ejemplares similares

Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies
por: Mansoor, Wasat, et al.
Publicado: (2021)

Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
por: Fuchs, Charles S., et al.
Publicado: (2017)

Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial
por: Yamaguchi, Kensei, et al.
Publicado: (2020)

The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancer
por: Hess, Lisa M., et al.
Publicado: (2020)

Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database
por: Karve, Sudeep, et al.
Publicado: (2015)

Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States
por: Mehta, Rutika, et al.
Publicado: (2023)

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer
por: Cuyún Carter, Gebra, et al.
Publicado: (2014)

Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data
por: Hess, Lisa M., et al.
Publicado: (2015)

Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies
por: Sashegyi, Andreas, et al.
Publicado: (2015)

Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States
por: Hess, Lisa M, et al.
Publicado: (2020)

Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
por: Barzi, Afsaneh, et al.
Publicado: (2019)

Non–Small Cell Lung Cancer Symptom Assessment Questionnaire: Psychometric Performance and Regulatory Qualification of a Novel Patient-Reported Symptom Measure
por: Bushnell, Donald M., et al.
Publicado: (2021)

Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data
por: Clouth, Johannes, et al.
Publicado: (2018)

Histological grade and other prognostic factors in relation to survival of patients with breast cancer.
por: Freedman, L. S., et al.
Publicado: (1979)

Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19
por: Lasky, Joseph A., et al.
Publicado: (2020)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)(†)
por: Obasaju, C., et al.
Publicado: (2013)

Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas
por: Levin, Victor A, et al.
Publicado: (2007)

Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
por: Necchi, Andrea, et al.
Publicado: (2020)

Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study
por: Tabernero, J, et al.
Publicado: (2018)

Phase Angle as a Prognostic Indicator of Survival in Institutionalized Psychogeriatric Patients
por: Barrera Ortega, Sara, et al.
Publicado: (2023)

Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers
por: Karve, Sudeep J, et al.
Publicado: (2014)

Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
por: Carter, Gebra Cuyun, et al.
Publicado: (2017)

Early Diagnosis and Prognostic Value of Acute Kidney Injury in Critically Ill Patients
por: Dobilienė, Diana, et al.
Publicado: (2019)

TIPS-08 ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA
por: Arrillaga-Romany, Isabel, et al.
Publicado: (2023)

How congruent are parent reports on 3–4-year-old children’s language skills with other sources of data?
por: Tulviste, Tiia, et al.
Publicado: (2023)

Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United Kingdom
por: La, Elizabeth M., et al.
Publicado: (2018)

Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
por: Park, Su Hyeong, et al.
Publicado: (2023)

Limited prognostic value of pain duration in non‐specific neck pain patients seeking chiropractic care
por: Guillén, David, et al.
Publicado: (2022)

Magnetic Resonance–Guided Focused Ultrasound for Patients With Painful Bone Metastases: Phase III Trial Results
por: Hurwitz, Mark D., et al.
Publicado: (2014)

Construction of a clinical survival prognostic model for middle-aged and elderly patients with stage III rectal adenocarcinoma
por: Liu, Hao, et al.
Publicado: (2021)

Experimental formation enthalpies for intermetallic phases and other inorganic compounds
por: Kim, George, et al.
Publicado: (2017)

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
por: Bird, Paul, et al.
Publicado: (2019)

Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
por: Montaño, Juan José, et al.
Publicado: (2021)

Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies
por: Saito, Yoji, et al.
Publicado: (2018)

Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma(†)
por: Al-Batran, S.-E., et al.
Publicado: (2016)

Management of adverse events in patients with hormone receptor-positive breast cancer treated with everolimus: observations from a phase III clinical trial
por: Peterson, Mary E.
Publicado: (2013)

The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I–III colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2023)

Prognostic factors for survival in soft tissue sarcoma.
por: el-Jabbour, J. N., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_j47iejdfnfu480kbgk8n9it3kj